Improgan, an analog of the histamine receptor antagonist cimetidine, produc
es highly effective analgesia following intraventricular injection. The pre
sent study examined changes in the antinociceptive effects of improgan foll
owing once daily intraventricular injections. Improgan (100-150 mu g) produ
ced near maximal antinociception 10 and 30 min after daily administration o
n all 4 test days, whereas comparable morphine treatments (50 mu g) induced
considerable tolerance. Thus, improgan produced highly effective analgesia
without the development of tolerance. (C) 1998 Elsevier Science B.V. All r
ights reserved.